Adherence to Opioids in Oncology Out Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03247504

Enrollment

300

Registered

2017-08-11

Start date

2018-05-17

Completion date

2019-11-30

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Out Patients With Opioids

Brief summary

Cancer pain is undertreated despite a good access to opioids in France. Although many factors are involved, the barriers related to the patient (and his family) are often reported .the reluctance of the patient or the family to take the prescribed medication is linked to misconceptions about the opioids , cultural barriers; or the lack of explanations provided by the physician. Some patients can have undiagnosed slight cognitive impairment .The situation is now more complicated as appear on the market the new form of opioids for the cancer breakthrough pain drug, adding one more opioid formulation in the prescription. The goal of the study is to measure the adherence to opioids in cancer out patients and the associated factors.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Cancer out patients with opioids by mouth prescription * Prescription than more than 8 days

Exclusion criteria

* Patient not at home, but in nursing home or other setting were the treatment are given by medical staff * Patient unable to answer at the questionnaire * Opoids given Intravenous or other way than mouth.

Design outcomes

Primary

Measure	Time frame
Rate of cancer out patients with a low adherence to the opioids treatment	One day

Countries

France

Contacts

Primary ContactMarilène FILBET

marilene.filbet@chu-lyon.fr478861482

Outcome results